Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 282,648 | 243,971 | 221,910 | 191,674 | 196,796 |
| Cost of Goods | 125,193 | 119,318 | 109,116 | 97,002 | 103,501 |
| Gross Profit | 157,455 | 124,653 | 112,794 | 94,672 | 93,295 |
| Operating Expenses | 158,230 | 151,064 | 143,684 | 136,352 | 128,856 |
| Operating Income | -582 | -26,093 | -30,774 | -41,678 | -35,060 |
| Interest Expense | 1,860 | 1,865 | 1,793 | 1,897 | 1,803 |
| Other Income | 2,458 | 5,344 | 2,824 | 4,046 | 5,553 |
| Pre-tax Income | 16 | -22,614 | -29,743 | -39,529 | -31,310 |
| Income Tax | -739 | 637 | 1,071 | 3,186 | -1,308 |
| Net Income Continuous | 755 | -23,251 | -30,814 | -42,715 | -30,002 |
| Net Income | $755 | $-23,251 | $-30,814 | $-42,715 | $-30,002 |
| EPS Basic Total Ops | N/A | -0.35 | -0.47 | -0.65 | -0.45 |
| EPS Basic Continuous Ops | 0.02 | -0.35 | -0.47 | -0.65 | -0.45 |
| EPS Diluted Total Ops | N/A | -0.35 | -0.47 | -0.65 | -0.45 |
| EPS Diluted Continuous Ops | 0.02 | -0.35 | -0.47 | -0.65 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.36 | -0.47 | -0.63 | N/A |
| EBITDA(a) | $2,439 | $-22,323 | $-25,449 | $-37,419 | $-30,126 |